$13.3 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 95 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 45.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AABA | ALTABA INC | $2,046,254,000 | +27.9% | 27,607,317 | 0.0% | 15.39% | +31.2% | |
| SPY | Buy | SPDR S&P 500 ETF TRput | $880,631,000 | +408.5% | 3,117,500 | +349.9% | 6.62% | +421.5% |
| CELG | New | CELGENE CORP | $795,286,000 | – | 8,430,000 | +100.0% | 5.98% | – |
| RHT | Buy | RED HAT INC | $608,345,000 | +29.0% | 3,329,749 | +24.0% | 4.58% | +32.3% |
| WAB | Buy | WABTEC CORP | $460,202,000 | +18.4% | 6,242,572 | +12.9% | 3.46% | +21.5% |
| GOOG | Sell | ALPHABET INCcap stk cl c | $342,991,000 | -28.7% | 292,328 | -37.1% | 2.58% | -26.8% |
| INFO | Buy | IHS MARKIT LTD | $332,128,000 | +17.0% | 6,107,546 | +3.2% | 2.50% | +20.0% |
| SPY | Sell | SPDR S&P 500 ETF TRcall | $324,005,000 | -82.7% | 1,147,000 | -84.7% | 2.44% | -82.3% |
| BKNG | Buy | BOOKING HLDGS INC | $322,777,000 | +13.2% | 184,982 | +11.8% | 2.43% | +16.2% |
| IQV | Sell | IQVIA HLDGS INC | $310,370,000 | -17.0% | 2,157,595 | -33.0% | 2.33% | -14.9% |
| FB | Sell | FACEBOOK INCcl a | $304,905,000 | -23.8% | 1,829,173 | -40.0% | 2.29% | -21.8% |
| TRU | Sell | TRANSUNION | $288,605,000 | -3.6% | 4,317,846 | -18.0% | 2.17% | -1.0% |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $279,935,000 | -9.1% | 806,938 | -25.3% | 2.10% | -6.7% |
| V | Sell | VISA INC | $251,572,000 | -17.8% | 1,610,679 | -30.6% | 1.89% | -15.7% |
| FIS | Buy | FIDELITY NATL INFORMATION SV | $240,283,000 | +23.4% | 2,124,515 | +11.9% | 1.81% | +26.5% |
| ANTM | Sell | ANTHEM INC | $236,759,000 | -14.1% | 825,000 | -21.4% | 1.78% | -11.9% |
| PLYA | PLAYA HOTELS & RESORTS NV | $233,531,000 | +6.1% | 30,606,930 | 0.0% | 1.76% | +8.9% | |
| EFX | Sell | EQUIFAX INC | $232,144,000 | +16.2% | 1,959,018 | -8.7% | 1.75% | +19.2% |
| CTXS | Buy | CITRIX SYS INC | $198,342,000 | +31.8% | 1,990,184 | +35.5% | 1.49% | +35.3% |
| MSFT | Sell | MICROSOFT CORP | $192,289,000 | -26.9% | 1,630,401 | -37.0% | 1.45% | -25.0% |
| SPGI | New | S&P GLOBAL INC | $191,927,000 | – | 911,551 | +100.0% | 1.44% | – |
| EQIX | Sell | EQUINIX INC | $188,859,000 | -51.8% | 416,759 | -62.5% | 1.42% | -50.6% |
| GD | Sell | GENERAL DYNAMICS CORP | $183,074,000 | -28.5% | 1,081,488 | -33.6% | 1.38% | -26.6% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $176,550,000 | +88.0% | 1,500,000 | +0.0% | 1.33% | +92.7% |
| SHW | New | SHERWIN WILLIAMS CO | $165,463,000 | – | 384,163 | +100.0% | 1.24% | – |
| SE | New | SEA LTDsponsored ads | $162,758,000 | – | 6,920,000 | +100.0% | 1.22% | – |
| AZN | ASTRAZENECA PLCsponsored adr | $157,071,000 | +6.5% | 3,885,000 | 0.0% | 1.18% | +9.1% | |
| CI | Sell | CIGNA CORP NEW | $151,975,000 | -24.2% | 945,000 | -10.4% | 1.14% | -22.2% |
| WCG | New | WELLCARE HEALTH PLANS INC | $151,060,000 | – | 560,000 | +100.0% | 1.14% | – |
| GG | New | GOLDCORP INC NEW | $148,262,000 | – | 12,960,000 | +100.0% | 1.12% | – |
| ARRY | Sell | ARRAY BIOPHARMA INC | $134,090,000 | +63.6% | 5,500,000 | -4.3% | 1.01% | +67.7% |
| ARRS | Buy | ARRIS INTERNATIONAL PLC | $118,379,000 | +8.2% | 3,745,000 | +4.6% | 0.89% | +11.0% |
| ZGNX | ZOGENIX INC | $112,798,000 | +50.9% | 2,050,500 | 0.0% | 0.85% | +54.7% | |
| XLRN | Buy | ACCELERON PHARMA INC | $110,604,000 | +20.9% | 2,375,000 | +13.1% | 0.83% | +24.0% |
| LBTYK | Sell | LIBERTY GLOBAL PLC | $104,299,000 | +2.4% | 4,308,106 | -12.7% | 0.78% | +5.0% |
| MYOK | Buy | MYOKARDIA INC | $101,395,000 | +29.7% | 1,950,278 | +21.9% | 0.76% | +33.2% |
| FOX | New | FOX CORP | $100,731,000 | – | 2,807,431 | +100.0% | 0.76% | – |
| LBTYA | Sell | LIBERTY GLOBAL PLC | $98,423,000 | -22.8% | 3,949,553 | -33.9% | 0.74% | -20.8% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $95,430,000 | +149.1% | 600,000 | +50.0% | 0.72% | +155.5% |
| ONCE | New | SPARK THERAPEUTICS INC | $93,382,000 | – | 820,000 | +100.0% | 0.70% | – |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $89,789,000 | +37.0% | 940,000 | +1.6% | 0.68% | +40.6% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $87,960,000 | +59.5% | 1,200,000 | -7.7% | 0.66% | +63.9% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $79,395,000 | +33.4% | 1,500,000 | +3.4% | 0.60% | +36.9% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $77,474,000 | +10.9% | 650,000 | +1.6% | 0.58% | +13.9% |
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $75,717,000 | -47.4% | 415,000 | -60.5% | 0.57% | -46.1% |
| EXEL | Buy | EXELIXIS INC | $71,400,000 | +81.5% | 3,000,000 | +50.0% | 0.54% | +86.5% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $67,470,000 | +41.6% | 3,250,000 | -7.1% | 0.51% | +45.3% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $64,103,000 | +63.2% | 750,000 | +7.1% | 0.48% | +67.4% |
| GRFS | Buy | GRIFOLS S Asp adr rep b nvt | $58,849,000 | +34.6% | 2,926,352 | +22.9% | 0.44% | +38.0% |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $54,445,000 | +7.5% | 5,725,000 | 0.0% | 0.41% | +10.2% | |
| NVCR | Sell | NOVOCURE LTD | $50,579,000 | +20.9% | 1,050,000 | -16.0% | 0.38% | +23.8% |
| FGEN | Buy | FIBROGEN INC | $49,762,000 | +43.4% | 915,579 | +22.1% | 0.37% | +47.2% |
| DIS | New | DISNEY WALT CO | $48,853,000 | – | 440,000 | +100.0% | 0.37% | – |
| NXPI | NXP SEMICONDUCTORS N V | $47,289,000 | +20.6% | 535,000 | 0.0% | 0.36% | +24.0% | |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $46,725,000 | +16.5% | 500,000 | -9.1% | 0.35% | +19.4% |
| FATE | Buy | FATE THERAPEUTICS INC | $43,925,000 | +55.6% | 2,500,000 | +13.6% | 0.33% | +59.4% |
| RDUS | RADIUS HEALTH INC | $40,740,000 | +20.9% | 2,043,149 | 0.0% | 0.31% | +23.9% | |
| SINA | New | SINA CORPord | $38,506,000 | – | 650,000 | +100.0% | 0.29% | – |
| ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $35,243,000 | +89.2% | 1,920,609 | +28.0% | 0.26% | +93.4% |
| CVS | Sell | CVS HEALTH CORP | $33,706,000 | -44.7% | 625,000 | -32.8% | 0.25% | -43.2% |
| RC | Buy | READY CAP CORP | $32,908,000 | +8.0% | 2,243,239 | +1.8% | 0.25% | +10.8% |
| PTCT | PTC THERAPEUTICS INC | $26,348,000 | +9.7% | 700,000 | 0.0% | 0.20% | +12.5% | |
| FOXA | New | FOX CORP | $26,035,000 | – | 709,220 | +100.0% | 0.20% | – |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $25,897,000 | -27.5% | 725,000 | -42.0% | 0.20% | -25.6% |
| CDXS | Buy | CODEXIS INC | $25,663,000 | +33.0% | 1,250,000 | +8.2% | 0.19% | +36.9% |
| STML | New | STEMLINE THERAPEUTICS INC | $25,700,000 | – | 2,000,000 | +100.0% | 0.19% | – |
| ZYME | ZYMEWORKS INC | $25,484,000 | +10.2% | 1,575,000 | 0.0% | 0.19% | +12.9% | |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $24,718,000 | +4.7% | 24,130,000 | 0.0% | 0.19% | +7.5% | ||
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $22,500,000 | +52.0% | 1,790,000 | -18.6% | 0.17% | +55.0% |
| QTNT | New | QUOTIENT LTD | $22,525,000 | – | 2,500,000 | +100.0% | 0.17% | – |
| CCXI | Buy | CHEMOCENTRYX INC | $20,835,000 | +31.7% | 1,500,000 | +3.4% | 0.16% | +35.3% |
| AVRO | Buy | AVROBIO INC | $19,845,000 | +83.4% | 900,000 | +38.5% | 0.15% | +88.6% |
| PGNX | PROGENICS PHARMACEUTICALS IN | $19,492,000 | +10.5% | 4,200,820 | 0.0% | 0.15% | +14.0% | |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $19,143,000 | +124.0% | 1,000,158 | +10.0% | 0.14% | +128.6% |
| SVRA | SAVARA INC | $17,872,000 | -2.6% | 2,425,000 | 0.0% | 0.13% | -0.7% | |
| BMS | BEMIS CO INC | $17,541,000 | +20.9% | 316,160 | 0.0% | 0.13% | +24.5% | |
| ZEAL | Buy | ZEALAND PHARMA A Ssponsored adr | $16,147,000 | +54.5% | 948,700 | +5.4% | 0.12% | +57.1% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $14,892,000 | -17.1% | 600,000 | -40.0% | 0.11% | -15.2% |
| Buy | CLOVIS ONCOLOGY INCnote 1.250% 5/0 | $14,438,000 | +37.8% | 18,750,000 | +27.1% | 0.11% | +41.6% | |
| CYCN | New | CYCLERION THERAPEUTICS INC | $12,500,000 | – | 844,085 | +100.0% | 0.09% | – |
| VSM | New | VERSUM MATLS INC | $10,565,000 | – | 210,000 | +100.0% | 0.08% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $9,572,000 | – | 400,000 | +100.0% | 0.07% | – |
| VOYA | VOYA FINL INC | $9,243,000 | +24.5% | 185,000 | 0.0% | 0.07% | +29.6% | |
| S | New | SPRINT CORPORATION | $8,984,000 | – | 1,590,000 | +100.0% | 0.07% | – |
| GOSS | New | GOSSAMER BIO INC | $8,188,000 | – | 377,852 | +100.0% | 0.06% | – |
| NVTA | New | INVITAE CORP | $7,026,000 | – | 300,000 | +100.0% | 0.05% | – |
| ZFGN | Buy | ZAFGEN INC | $4,932,000 | -43.9% | 1,800,000 | +1.4% | 0.04% | -42.2% |
| PFNX | PFENEX INC | $3,708,000 | +93.7% | 600,000 | 0.0% | 0.03% | +100.0% | |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $3,655,000 | -80.0% | 500,000 | -75.0% | 0.03% | -79.9% |
| GCVRZ | SANOFIright 12/31/2020 | $3,073,000 | -6.2% | 6,827,805 | 0.0% | 0.02% | -4.2% | |
| APTX | APTINYX INC | $2,714,000 | -75.5% | 670,000 | 0.0% | 0.02% | -75.3% | |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $1,969,000 | -75.1% | 100,000 | -71.4% | 0.02% | -74.1% |
| New | RADIUS HEALTH INCnote 3.000% 9/0 | $1,045,000 | – | 1,250,000 | +100.0% | 0.01% | – | |
| TBIO | Sell | TRANSLATE BIO INC | $1,019,000 | -72.8% | 100,000 | -80.0% | 0.01% | -70.4% |
| GOL | New | GOL LINHAS AEREAS INTLG S Aspon adr pfd new | $189,000 | – | 14,498 | +100.0% | 0.00% | – |
| RMED | Exit | RA MED SYS INC | $0 | – | -38,313 | -100.0% | -0.00% | – |
| TYME | Exit | TYME TECHNOLOGIES INC | $0 | – | -300,857 | -100.0% | -0.01% | – |
| AVA | Exit | AVISTA CORP | $0 | – | -62,900 | -100.0% | -0.02% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -250,000 | -100.0% | -0.02% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -95,365 | -100.0% | -0.02% | – |
| BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -1,000,000 | -100.0% | -0.02% | – |
| THOR | Exit | SYNTHORX INC | $0 | – | -386,092 | -100.0% | -0.05% | – |
| MLNX | Exit | MELLANOX TECHNOLOGIES LTD | $0 | – | -95,000 | -100.0% | -0.06% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -350,000 | -100.0% | -0.07% | – |
| ILPT | Exit | INDUSTRIAL LOGISTICS PPTYS T | $0 | – | -610,545 | -100.0% | -0.09% | – |
| QTNT | Exit | QUOTIENT LTD | $0 | – | -2,400,000 | -100.0% | -0.11% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -87,000 | -100.0% | -0.11% | – |
| BUD | Exit | ANHEUSER BUSCH INBEV SA/NVsponsored adr | $0 | – | -275,843 | -100.0% | -0.13% | – |
| ORBK | Exit | ORBOTECH LTDord | $0 | – | -535,721 | -100.0% | -0.22% | – |
| BPY | Exit | BROOKFIELD PPTY PARTNERS L Punit ltd partn | $0 | – | -2,075,000 | -100.0% | -0.24% | – |
| P | Exit | PANDORA MEDIA INC | $0 | – | -9,205,000 | -100.0% | -0.55% | – |
| TSRO | Exit | TESARO INC | $0 | – | -1,700,000 | -100.0% | -0.92% | – |
| VRSK | Exit | VERISK ANALYTICS INC | $0 | – | -1,441,194 | -100.0% | -1.15% | – |
| TLRY | Exit | TILRAY INC | $0 | – | -2,479,515 | -100.0% | -1.19% | – |
| DELL | Exit | DELL TECHNOLOGIES INCcl c | $0 | – | -3,572,062 | -100.0% | -1.28% | – |
| SMH | Exit | VANECK VECTORS ETF TRput | $0 | – | -2,150,000 | -100.0% | -1.38% | – |
| FOX | Exit | TWENTY FIRST CENTY FOX INCcl b | $0 | – | -7,745,000 | -100.0% | -2.71% | – |
| FOXA | Exit | TWENTY FIRST CENTY FOX INCcl a | $0 | – | -12,792,300 | -100.0% | -4.51% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.